This poses a challenge for clinical management and genetic counseling; for example, a definitive genetic diagnosis cannot be made for some patients with low GGT cholestasis, and biallelic MYO5B VUSs identified due to caution should be exercised in clinical diagnostics regarding VUSs. Here, MYO5B is linked to cholestasis.